Topic 15 Procoagulants and Antifibrinolytics Flashcards
(37 cards)
Protamine acid base status?
strongly-cationic (positive)
Protamine by itself is a what?
is an anticoagulant: it decreases thrombin generation by inhibiting Factor V activation
Protamine median T1/2?
5 minutes
Heparins median T1/2
1-2 hours
Protamine is a component of what insulin?
NPH - Neutral Protamine Hagedorn
Protamine effectiveness in reversing LMWH?
Only partially/unpredictably reverses LMWH. (which sort of limits LMWH’s use.)
Protamines effect on fondaparinux?
*Protamine has no effect on fondaparinux
Two probs with Protamine?
its an anticoagulant
can have protamine reactions
How to administer Protamine?
SLOWLY
Contributing factors to Protamine Reactions? (5)
- Redo Surgeries
- Fish allergies
- Diabetics (bc in insulin)
- Vasectomy (why?)
- ”Excessive” dosage - (give slow and right amount)
Protamine Reactions are minimized by what?
Slow administration
-Intra-aortic administration (why?)
-Administration with steroids and
antihistamines.
Vitamin K is essential for production of what factors?
F II, VII, IX, X
F (2, 7, 9, 10)
Prothrombin, Proconvertin, Christmas and Stuart Factors
Two types of Vitamin K
1) K₁:Phytonadione (Mephyton)
2) K₂:Menaquinone
The most “clinically” relevant form of Vitamin K for perfusionists
K₁:Phytonadione (Mephyton)
How to administer Vitamin K?
MUST give slow IV bc anaphylaxis is a common side affect
requires at least 6 hours to be effective
What is a typical FFP dose for Warfarin over-activity?
15ml/kg
Antifibrinolytic Drugs? (2)
Aminocaproic Acid (EACA) (Amicar)
- Tranexamic Acid (Cyklokapron, Lysteda)
- Both are synthetic derivatives of the amino acid lysine.
- Statistically clinically indistinguishable, except TA is 10x stronger than Amicar
Aminocaproic Acid
Amicar, EACA
Antifibrinolytic Drug
Tranexamic Acid (TA)
Cyklokapron, Lysteda
Antifibrinolytic Drug 10X stronger than Amicar
Amicar
Aminocaproic Acid
Antifibrinolytic Drug
Cyklokapron, Lysteda
Tranexamic Acid
Antifibrinolytic Drug (10x stranger than Amicar)
Both Antifibrinolytic Drugs prevent activation of what and reduce what?
Amicar (Aminocaproic Acid) and Tranexamix Acid (Cyklokapron/Lysteda)
prevent plasminogen activation and directly inhibit plasmin which prevents fibrinolysis
•Both significantly reduce post- bypass hemorrhage, especially in patients who have received previous fibrinolytic therapy
Aprotinin
Trasylol
Serine Protease Inhibitor (caused renal probs and has been pulled from the market and is now used for investigational/compassionate use)
Trasylol
Aprotinin
Serine Protease Inhibitor (cause renal probs and has been pulled from the market and is now used for investigational/compassionate use)